Climb Bio (CLYM) Change in Acquisitions & Divestments (2022 - 2026)

Climb Bio filings provide 5 years of Change in Acquisitions & Divestments readings, the most recent being $31.9 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments rose 99.37% to $31.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $127.0 million through Mar 2026, up 452.18% year-over-year, with the annual reading at $111.1 million for FY2025, 435.41% up from the prior year.
  • Change in Acquisitions & Divestments hit $31.9 million in Q1 2026 for Climb Bio, up from $30.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $55.3 million in Q3 2022 and bottomed at $7.0 million in Q4 2024.
  • Average Change in Acquisitions & Divestments over 5 years is $27.6 million, with a median of $25.5 million recorded in 2025.
  • The largest annual shift saw Change in Acquisitions & Divestments crashed 80.95% in 2024 before it skyrocketed 336.26% in 2025.
  • Climb Bio's Change in Acquisitions & Divestments stood at $21.0 million in 2022, then surged by 75.06% to $36.7 million in 2023, then crashed by 80.95% to $7.0 million in 2024, then surged by 336.26% to $30.5 million in 2025, then grew by 4.47% to $31.9 million in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Change in Acquisitions & Divestments are $31.9 million (Q1 2026), $30.5 million (Q4 2025), and $39.1 million (Q3 2025).